BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16470859)

  • 1. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma.
    Levine PH; Joutovsky A; Cangiarella J; Yee H; Simsir A
    Diagn Cytopathol; 2006 Mar; 34(3):191-5. PubMed ID: 16470859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
    Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
    Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of CDX-2 expression in separating metastatic gastrointestinal adenocarcinoma from other metastatic adenocarcinoma in fine-needle aspiration cytology using cell blocks.
    Saad RS; Essig DL; Silverman JF; Liu Y
    Cancer; 2004 Jun; 102(3):168-73. PubMed ID: 15211476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
    Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDX-2 immunostaining in primary and secondary ovarian carcinomas.
    Tornillo L; Moch H; Diener PA; Lugli A; Singer G
    J Clin Pathol; 2004 Jun; 57(6):641-3. PubMed ID: 15166272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray.
    Kim MJ
    J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.
    Li HC; Schmidt L; Greenson JK; Chang AC; Myers JL
    Am J Clin Pathol; 2009 Jan; 131(1):129-33. PubMed ID: 19095576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
    Raspollini MR; Baroni G; Taddei A; Taddei GL
    Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors.
    Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C
    Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
    Raspollini MR; Nesi G; Baroni G; Girardi LR; Taddei GL
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):358-62. PubMed ID: 16280666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
    Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
    Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX-2 expression is reduced in colorectal carcinomas with solid growth pattern and proximal location, but is largely independent of MSI status.
    OkoĊ„ K; Zazula M; Rudzki Z; Papla B; Osuch C; Stachura J
    Pol J Pathol; 2004; 55(3):9-14. PubMed ID: 15619975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX-2 should be included in the work-up of patients with lung metastases from unknown primary.
    Fazio N; De Pas T; de Braud F; Spaggiari L; Mazzarol G; Biffi R; Andreoni B; Zampino M; Curigliano G; Lorizzo K; Di Meglio G; Goldhirsch A
    Ann Oncol; 2004 Dec; 15(12):1850. PubMed ID: 15550596
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.